BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11919724)

  • 21. Effectiveness of antibacterial prophylaxis with non-absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation.
    Koh S; Yamada K; Nishimoto M; Hayashi Y; Koh H; Nakashima Y; Nakane T; Hirose A; Nakamae M; Kakeya H; Hino M; Nakamae H
    Transpl Infect Dis; 2015 Oct; 17(5):647-54. PubMed ID: 26134140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.
    Narreddy S; Mellon-Reppen S; Abidi MH; Klein JL; Peres E; Heilbrun LK; Smith D; Alangaden G; Chandrasekar PH
    Transpl Infect Dis; 2007 Mar; 9(1):3-10. PubMed ID: 17313464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [7/10 Antibiotic drug therapy and infectious risk].
    Soins; 2007 Sep; (718):59-60. PubMed ID: 17970578
    [No Abstract]   [Full Text] [Related]  

  • 24. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation.
    Leung AY; Chan MT; Yuen KY; Cheng VC; Chan KH; Wong CL; Liang R; Lie AK; Kwong YL
    Clin Infect Dis; 2005 Feb; 40(4):528-37. PubMed ID: 15712075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization.
    Kachroo S; Dao T; Zabaneh F; Reiter M; Larocco MT; Gentry LO; Garey KW
    Ann Pharmacother; 2006 Mar; 40(3):381-5. PubMed ID: 16478809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
    Fraser GA; Walker II;
    Biol Blood Marrow Transplant; 2004 May; 10(5):287-97. PubMed ID: 15111928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
    Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
    Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
    Plantinga TS; van der Velden WJ; Ferwerda B; van Spriel AB; Adema G; Feuth T; Donnelly JP; Brown GD; Kullberg BJ; Blijlevens NM; Netea MG
    Clin Infect Dis; 2009 Sep; 49(5):724-32. PubMed ID: 19614557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Zygomycosis after hematogeneic stem cell transplantation--a current problem?].
    Glöckner A; Cornely OA
    Med Klin (Munich); 2006 Sep; 101(9):724-9. PubMed ID: 16977397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusarium infection in hematopoietic stem cell transplant recipients.
    Nucci M; Marr KA; Queiroz-Telles F; Martins CA; Trabasso P; Costa S; Voltarelli JC; Colombo AL; Imhof A; Pasquini R; Maiolino A; Souza CA; Anaissie E
    Clin Infect Dis; 2004 May; 38(9):1237-42. PubMed ID: 15127334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The current status of vaccination and antibiotic prophylaxis in splenectomy. I: Adults].
    Funk EM; Schlimok G; Ehret W; Witte J
    Chirurg; 1997 Jun; 68(6):586-90. PubMed ID: 9324436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hematopoietic stem cell transplantation after surgical resection of pulmonary aspergillosis in 5 patients with acute leukemia.
    Motohashi K; Ito S; Hagihara M; Sakai R; Tanaka M; Kawano T; Maruta A; Ishigatsubo Y; Kanamori H
    Rinsho Ketsueki; 2009 May; 50(5):430-4. PubMed ID: 19483405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of intravenous pentamidine prophylaxis to prevent pneumocystis pneumonia in a pediatric hematopoietic stem cell transplant (HSCT) patient.
    Milstone AM; Balakrishnan SL; Foster CB; Chen A
    Pediatr Blood Cancer; 2006 Nov; 47(6):859-60. PubMed ID: 16568443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.